STORLINO, GIUSEPPINA
 Distribuzione geografica
Continente #
NA - Nord America 750
EU - Europa 325
AS - Asia 150
SA - Sud America 4
Totale 1.229
Nazione #
US - Stati Uniti d'America 748
IT - Italia 208
CN - Cina 79
SE - Svezia 60
SG - Singapore 42
GB - Regno Unito 14
IN - India 14
DE - Germania 12
VN - Vietnam 10
BE - Belgio 8
FR - Francia 7
CZ - Repubblica Ceca 5
FI - Finlandia 5
BR - Brasile 3
AT - Austria 2
CA - Canada 2
KZ - Kazakistan 2
BG - Bulgaria 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
JP - Giappone 1
NL - Olanda 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.229
Città #
Fairfield 108
Bari 103
Chandler 84
Ashburn 79
Woodbridge 79
Seattle 52
Nyköping 51
Houston 43
Wilmington 43
Ann Arbor 34
Cambridge 34
New York 23
Singapore 23
Grumo Appula 21
Roxbury 14
Beijing 13
Pune 13
Des Moines 11
Trani 11
Dong Ket 10
Lawrence 10
Nanjing 10
Brussels 8
Inglewood 8
Munich 8
Rome 8
Dearborn 6
Guangzhou 6
Milan 6
San Diego 6
Changsha 5
Helsinki 5
Los Angeles 5
Brno 4
Brooklyn 4
Falls Church 4
Hefei 4
Shanghai 4
Jiaxing 3
Kunming 3
London 3
Novara 3
Paris 3
Randazzo 3
Shenyang 3
Washington 3
Astana 2
Boardman 2
Bologna 2
Grottaglie 2
Jinan 2
Nanchang 2
Redwood City 2
Santa Clara 2
Tianjin 2
Toronto 2
Turin 2
Vercelli 2
Vienna 2
Wuhan 2
Amsterdam 1
Bhopal 1
Boydton 1
Casoria 1
Curvelo 1
Dublin 1
Florence 1
Frankfurt am Main 1
Guayaquil 1
Hebei 1
Islington 1
Istanbul 1
Jian 1
Kilburn 1
Monte Carmelo 1
Ningbo 1
Noicattaro 1
Olomouc 1
Osaka 1
Prescot 1
Qingdao 1
Quanzhou 1
Redmond 1
Rio de Janeiro 1
Sofia 1
Taranto 1
Tiantai Chengguanzhen 1
Xi'an 1
Xian 1
Zhengzhou 1
Zibo 1
Totale 1.043
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 143
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 129
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 126
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 112
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 109
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 85
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 67
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 62
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 59
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 59
null 57
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 57
LIGHT as regulator of bone homeostasis during osteolytic bone metastasis formation in non-small cell lung cancer patients 49
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 45
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 34
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 33
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 23
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 16
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 15
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 14
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 12
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 11
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 10
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 8
Totale 1.335
Categoria #
all - tutte 6.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 0 0 0 0 16 18 26 47 31 26 10 11
2020/2021331 31 15 15 10 26 20 43 51 61 20 20 19
2021/2022160 24 1 1 1 14 19 5 2 26 8 20 39
2022/2023214 14 31 19 11 14 31 8 30 32 1 9 14
2023/2024169 15 22 12 8 11 49 12 7 1 14 3 15
2024/2025156 65 6 34 32 19 0 0 0 0 0 0 0
Totale 1.335